Publication:
Bacillus Calmette-Guerin, Mycobacterium bovis, as an immunomodulator in atopic diseases

dc.contributor.authorsBarlan, I; Bahceciler, NN; Akdis, M; Akdis, CA
dc.date.accessioned2022-03-12T17:20:24Z
dc.date.accessioned2026-01-11T19:23:17Z
dc.date.available2022-03-12T17:20:24Z
dc.date.issued2006
dc.description.abstractBased on the hygiene hypothesis association between atopy and bacillus Calmette-Guerin (BCG), purified protein derivative skin test reaction, mycobacterial disease, and environmental mycobacteria are summarized. The role of mycobacterial species in the activation of the innate immune response through Toll-like receptors is mentioned. The implications and perspectives of BCG as a potential therapeutic adjuvant in atopic disease are discussed.
dc.identifier.doi10.1016/j.iac.2006.02.002
dc.identifier.issn0889-8561
dc.identifier.pubmed16701150
dc.identifier.urihttps://hdl.handle.net/11424/228232
dc.identifier.wosWOS:000238160100014
dc.language.isoeng
dc.publisherW B SAUNDERS CO-ELSEVIER INC
dc.relation.ispartofIMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectTOLL-LIKE RECEPTORS
dc.subjectBCG VACCINATION
dc.subjectENVIRONMENTAL MYCOBACTERIA
dc.subjectTUBERCULIN REACTIVITY
dc.subjectIMMUNOGLOBULIN-E
dc.subjectAIRWAY HYPERRESPONSIVENESS
dc.subjectINVERSE ASSOCIATION
dc.subjectCELLULAR ACTIVATION
dc.subjectALLERGIC RESPONSE
dc.subjectIMMUNE-RESPONSES
dc.titleBacillus Calmette-Guerin, Mycobacterium bovis, as an immunomodulator in atopic diseases
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage+
oaire.citation.issue2
oaire.citation.startPage365
oaire.citation.titleIMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
oaire.citation.volume26

Files